Platform
Company
Complete Blood Count
Review status
Currently under review
Pending specialist review and validation.
The absolute reticulocyte count measures the number of young red blood cells circulating in your bloodstream. Reticulocytes are immature red cells newly released from the bone marrow, and automated analyzers can detect them because they still contain small amounts of RNA.
This test shows how actively your bone marrow is making red blood cells. It is commonly ordered along with a complete blood count to help clarify whether anemia or other concerns are due to reduced production or to increased loss or destruction of red cells.
This test helps your clinician find the cause of anemia, assess recovery after bleeding, and monitor response to treatments such as iron, vitamin B12 or folate replacement, or medicines that stimulate red cell production. It can also help evaluate conditions where red blood cells are being destroyed more quickly than usual.
A higher count often reflects increased bone marrow activity, which can be an appropriate response to blood loss or destruction. A lower count points to reduced production, which may occur with nutrient deficiencies, chronic kidney disease, bone marrow disorders, infections, inflammation, or effects from chemotherapy or other medicines. Understanding the pattern guides treatment decisions and the need for additional tests.
Your result is interpreted together with other information such as hemoglobin, red blood cell indices, iron studies, kidney function, and your symptoms and history. Patterns over time are often more informative than a single result, especially after starting or changing therapy.
If your count is outside the expected range, your clinician may confirm the result, review medications and supplements, look for signs of bleeding or red cell breakdown, and order follow-up tests tailored to your situation. Most causes are manageable, and treatment focuses on correcting the underlying reason. Do not start or change medications or supplements without medical advice.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Active bleeding or conditions that break down red cells can raise the reticulocyte count as your bone marrow responds. Your clinician will consider any recent surgery, injury, heavy menstrual bleeding, jaundice, or dark urine.
Shortages of iron, vitamin B12, or folate reduce red cell production and can lower the reticulocyte count. After replacement therapy, a temporary rise in reticulocytes is often seen as the marrow recovers.
The kidneys make erythropoietin, a hormone that signals the marrow to produce red cells. Kidney disease can lower this signal and reduce reticulocytes. Medicines that stimulate erythropoiesis can increase the count.
Chemotherapy, some immunosuppressants, and other marrow-suppressing drugs can lower the count. Excess alcohol intake may also blunt marrow response. Always tell your clinician about all medicines and substances you use.
A blood transfusion can temporarily mask your own marrow response, and the timing of testing after starting treatment affects results. Your clinician may repeat the test to track the recovery pattern.
This test does not require fasting, but proper collection and prompt analysis are important. Delays, clotted samples, or incorrect tubes can affect automated measurements and may require a repeat draw.
References